Skip to content

A Study To Compare The Effect Of Hinguvachadi Gulika(tablet) And Rajapravartini Vati (tablet) With Saptasara Kashaya (Medicated decoction) In The Management Of Udavartini Yonivyapat vis-a-vis Painful menstrual periods.

AN OPEN LABEL DOUBLE ARM CLINICAL STUDY TO COMPARE THE EFFECT OF HINGUVACHADI GULIKA AND RAJAPRAVARTINI VATI WITH SAPTASARA KASHAYA IN THE MANAGEMENT OF UDAVARTINI YONIVYAPAT vis-a-vis PRIMARY DYSMENORRHOEA - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037219
Enrollment
40
Registered
2021-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Both married and unmarried female patients between the age group of 14 - 30 years 2) Patients suffering from pain during menstruation for more than 2 consecutive menstrual cycles. 3) Post covid and non-covid subjects fulfilling the above criteria.

Exclusion criteria

Exclusion criteria: 1) Female patients diagnosed with any other underlying pelvic pathology and menstrual irregularities. 2) Patients with history of any other systemic illnesses that may interfere with the course of treatment.

Design outcomes

Primary

MeasureTime frame
Assessment criteria for pain will be based on Visual analogue scale and Verbal multi-dimensional scoring system. the following will be measured â?¢Pain in lower abdomen â?¢Pain in medial aspects of thigh. â?¢Lower Backache â?¢Duration of pain â?¢Rajah krucchra vimunchana â?¢Arthavam sa vimukte tu tatkshnam labhate sukham â?¢Nausea â?¢Vomiting â?¢Headache Timepoint: Study will be conducted for 3 consecutive menstrual cycles. Before treatment â?? assessment will be done on the 1st day of the 1st menstrual cycle. During treatmentâ?? assessment will be done on the 1st day of the 2nd menstrual cycle. After treatment â?? assessment will be done on the 1st day of 3rd menstrual cycle. Follow up- assessment will be done on the 1st day of 4rd menstrual cycle.

Secondary

MeasureTime frame
nilTimepoint: not applicable

Countries

India

Contacts

Public ContactDR PAPIYA JANA

Sri kalabyraveshwara swamy ayurvedic medical college hospital and Research centre bangalore

drpapiya@gmail.com9886716216

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026